Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Programme

FP7
All
FP7-HEALTH (196)

Country

Albania (1)
Argentina (2)
Australia (7)
Austria (35)
Bangladesh (2)
Belgium (61)
Benin (2)
Bosnia and Herzegovina (1)
Brazil (3)
Bulgaria (1)
Burkina Faso (1)
Cambodia (1)
Canada (5)
Chile (1)
China (2)
Colombia (1)
Croatia (5)
Cuba (1)
Cyprus (2)
Czech Republic (12)
Denmark (34)
Estonia (9)
Ethiopia (3)
Finland (21)
France (124)
French Polynesia (1)
Germany (170)
Greece (17)
Guatemala (1)
Hong Kong (1)
Hungary (15)
Iceland (7)
India (2)
Indonesia (2)
Ireland (35)
Israel (26)
Italy (94)
Japan (2)
Kenya (2)
Latvia (1)
Lithuania (1)
Luxembourg (4)
Malawi (2)
Malaysia (1)
Malta (1)
Mexico (1)
Moldova (1)
Mozambique (1)
Nepal (1)
Netherlands (114)
New Zealand (2)
Nigeria (2)
Norway (17)
Peru (1)
Poland (7)
Portugal (9)
Romania (5)
Russia (1)
Senegal (1)
Serbia (1)
Singapore (2)
Slovakia (1)
Slovenia (6)
South Africa (4)
Spain (74)
Sri Lanka (1)
Sudan (1)
Sweden (71)
Switzerland (56)
Taiwan (2)
Tanzania (1)
Thailand (2)
The Gambia (1)
Turkey (7)
Uganda (2)
Ukraine (2)
United Kingdom (170)
United States (28)
Uruguay (1)

Language

English (196)

Advanced search

Results 1 - 10 of 196
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes
ID: 258967
Start date: 2011-01-01, End date: 2018-06-30
Cancer genotyping has identified a number of correlations between mutations in specific genes and responses to targeted anti-cancer drugs, with many mutations occurring in kinases or downstream signaling components. While there are several ongoing large-scale genome re-sequen...
Programme: FP7-HEALTH
Record Number: 97660
Last updated on: 2017-07-16
Clinical Development of Nitisinone for Alkaptonuria
ID: 304985
Start date: 2012-11-01, End date: 2018-04-30
DevelopAKUre is a proposal to fund the clinical development of an orphan designated drug, nitisinone, for the treatment of a rare Mendelian disease, Alkaptonuria (AKU). AKU is a genetic deficiency of homogentisic acid dioxygenase, causing high levels of homogentisic acid (HGA...
Programme: FP7-HEALTH
Record Number: 106157
Last updated on: 2017-07-12
Social Innovations Promoting Active and Healthy Ageing
ID: 306058
Start date: 2012-12-01, End date: 2015-11-30
INNOVAGE is an ambitious project is dedicated to developing and testing, as well as surveying and cataloguing, social innovations that will have a solid impact on improving the quality of life and well-being of older people. In particular the project aims to make a major cont...
Programme: FP7-HEALTH
Record Number: 105830
Last updated on: 2017-06-05
Personal Health Systems Foresight
[PROJECT] PHS FORESIGHT - Personal Health Systems Foresight
ID: 305801
Start date: 2012-09-01, End date: 2014-08-31
This support action will coordinate strategic stakeholder engagements in the realm of Personal Health Systems (PHS) within and beyond European Union up to 2030. PHS assist in the provision of continuous, quality controlled and personalised health services to empowered individ...
Programme: FP7-HEALTH
Record Number: 105555
Last updated on: 2017-06-05
Orphans Unite: chILD better together –
European Management Platform for Childhood Interstitial Lung Diseases
ID: 305653
Start date: 2012-12-01, End date: 2016-11-30
Children with diffuse lung disease, also called childhood interstitial lung diseases (chILD), may have one of more than 200 entities, the biggest group of respiratory orphan lung diseases. Frequently undiagnosed because of lack of awareness or complex differential diagnosis, ...
Programme: FP7-HEALTH
Record Number: 106276
Last updated on: 2017-06-05
Rapid development and distribution of statistical tools for high-throughput sequencing data
ID: 305626
Start date: 2012-12-01, End date: 2015-11-30
High-throughput sequencing (HTS) is a powerful and rapidly evolving family of technologies with a multitude of applications. They include genetics of rare and common diseases, understanding of disease mechanism and progression through transcriptome and epigenome profiling, ca...
Programme: FP7-HEALTH
Record Number: 105701
Last updated on: 2017-06-05
To decipher the optimal management of systemic sclerosis
ID: 305495
Start date: 2012-12-01, End date: 2015-11-30
The current approach to diagnosis and management of the rare disease systemic sclerosis (SSc) is based on American College of Rheumatology criteria with low sensitivity and few validated recommendations for the therapy of the disease and its manifold organ manifestations. To ...
Programme: FP7-HEALTH
Record Number: 106189
Last updated on: 2017-06-05
Best EScalation Treatment in Multiple Sclerosis (MS)
ID: 305477
Start date: 2012-11-01, End date: 2016-10-31
"Multiple Sclerosis (MS) is a devastating disease of the central nervous system affecting 2.5 million worldwide. MS is a field of constant therapeutic innovation, a fact which brings hope to young adults since MS is one of the most frequent causes of severe handicap. A major ...
Programme: FP7-HEALTH
Record Number: 106260
Last updated on: 2017-06-05
A Europe-wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptable HLA Mismatches
ID: 305385
Start date: 2012-12-01, End date: 2015-11-30
The presence of donor specific HLA antibodies is a contra-indication for renal transplantation. Highly sensitized patients accumulate and often die on the transplant waiting lists as it is almost impossible to find donors towards which they don’t have antibodies. The acceptab...
Programme: FP7-HEALTH
Record Number: 106298
Last updated on: 2017-06-05
A phase I/IIa clinical trial in Duchenne muscular dystrophy using systemically delivered morpholino antisense oligomer to skip exon 53
ID: 305370
Start date: 2012-11-01, End date: 2016-04-30
Duchenne muscular dystrophy (DMD) is a progressive, lethal muscle degenerative condition arising from the absence of dystrophin in skeletal and cardiac muscles. 65% of DMD boys have out-of-frame deletions. Modulation of pre-mRNA splicing by exon skipping is the most promising...
Programme: FP7-HEALTH
Record Number: 106018
Last updated on: 2017-06-05
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-07-26
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top